Summary - ARGX - NASDAQ - Weiss Ratings

D

argenx SE ARGX

$619.97 $8.791.44%

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$349.86 - $678.21

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

--

Headlines

argenx SE (ARGX, $611.18) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 18, 2025

3/19/2025 - Tickeron - Stocks

HighTower Advisors LLC Buys 6,006 Shares of argenx SE (NASDAQ:ARGX)

3/19/2025 - MarketBeat

argenx (NASDAQ:ARGX) Upgraded to Outperform at Sanford C. Bernstein

3/18/2025 - MarketBeat

Evercore ISI Reaffirms Their Buy Rating on Argenx Se (ARGX)

3/18/2025 - TipRanks Financial Blog

ANTIPODES PARTNERS Ltd Increases Holdings in argenx SE (NASDAQ:ARGX)

3/13/2025 - Ticker Report

argenx (NASDAQ:ARGX) Rating Increased to Hold at Deutsche Bank Aktiengesellschaft

3/12/2025 - MarketBeat

Artisan Small Cap Fund Sold argenx SE (ARGX) as it Exceeded Small-Cap Mandate

3/11/2025 - Insider Monkey

argenx (NASDAQ:ARGX) Price Target Raised to $1,100.00

3/10/2025 - MarketBeat

Assetmark Inc. Acquires 879 Shares of argenx SE (NASDAQ:ARGX)

3/9/2025 - MarketBeat

argenx SE (ARGX, $594.21) RSI Indicator left the oversold zone on March 07, 2025

3/8/2025 - Tickeron - Stocks

argenx SE (NASDAQ:ARGX) Receives Average Rating of "Moderate Buy" from Analysts

3/8/2025 - MarketBeat

argenx SE (NASDAQ:ARGX) Shares Sold by Candriam S.C.A.

3/7/2025 - MarketBeat

US Bancorp DE Has $3 Million Stock Holdings in argenx SE (NASDAQ:ARGX)

3/7/2025 - MarketBeat

argenx SE (ARGX) Announces Promising Data for VYVGART at AAN Annual Meeting

3/7/2025 - GuruFocus

argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting

3/7/2025 - Globe Newswire

J.Safra Asset Management Corp Boosts Stock Position in argenx SE (NASDAQ:ARGX)

3/6/2025 - Ticker Report

argenx (NASDAQ:ARGX) Price Target Raised to $680.00

3/4/2025 - MarketBeat

Stifel Nicolaus Sticks to Their Buy Rating for Argenx Se (ARGX)

3/4/2025 - TipRanks Financial Blog

Oppenheimer Issues Positive Forecast for argenx (NASDAQ:ARGX) Stock Price

3/1/2025 - MarketBeat

Wells Fargo & Company Forecasts Strong Price Appreciation for argenx (NASDAQ:ARGX) Stock

3/1/2025 - MarketBeat

argenx (NASDAQ:ARGX) Earns Outperform Rating from William Blair

3/1/2025 - MarketBeat

argenx (NASDAQ:ARGX) Given New $720.00 Price Target at HC Wainwright

3/1/2025 - MarketBeat

Ieq Capital LLC Purchases Shares of 440 argenx SE (NASDAQ:ARGX)

3/1/2025 - MarketBeat

argenx (NASDAQ:ARGX) Announces Quarterly Earnings Results

2/28/2025 - MarketBeat

Argenx Se (ARGX) Gets a Buy from Scotiabank

2/28/2025 - TipRanks Financial Blog

Income Statement

Total Revenue (TTM)

--

EBITDA (TTM)

--

EBIT (TTM)

--

Net Income (TTM)

--

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

--

Cash from Investing (TTM)

--

Cash from Financing (TTM)

--

Net Change in Cash (TTM)

--

Filings

Filing Date

Thursday, July 25, 2024

Period Date

Sunday, June 30, 2024

Next Filing

(est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Mar 20, 2024 - $349.86

52-week High

Jan 14, 2025 - $678.21

Valuation

Market Cap

$37.49B - Large Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

Phone Number

31 10 703 8441

Address

Laarderhoogtweg 25
Amsterdam, 1101EB

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China... more